These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 32059072

  • 1. The multicomponent medication Spascupreel attenuates stress-induced gut dysfunction in rats.
    Theodorou V, Beaufrand C, Yvon S, Laforge G, Burmeister Y, Müller A, Seilheimer B, Bueno L, Eutamene H.
    Neurogastroenterol Motil; 2020 May; 32(5):e13798. PubMed ID: 32059072
    [Abstract] [Full Text] [Related]

  • 2. [Effects of heat-sensitive moxibustion on HPA axis in rats with irritable bowel syndrome].
    Zhang H, Xie F, Gong H, Huang H, Chen S, Kang M, Fu Y.
    Zhongguo Zhen Jiu; 2017 Dec 12; 37(12):1315-21. PubMed ID: 29354998
    [Abstract] [Full Text] [Related]

  • 3. Translational evaluation of Gelsectan® effects on gut barrier dysfunction and visceral pain in animal models and irritable bowel syndrome with diarrhoea.
    Inczefi O, Eutamene H, Placide F, Tondereau V, Pallagi P, Bagyánszki M, Bódi N, Gémes N, Szebeni G, Molnár T, Theodorou V, Róka R.
    United European Gastroenterol J; 2024 Oct 12; 12(8):1102-1113. PubMed ID: 39106086
    [Abstract] [Full Text] [Related]

  • 4. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.
    Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, Ameen VZ, Mayer EA.
    Neurogastroenterol Motil; 2009 Feb 12; 21(2):149-59. PubMed ID: 18684212
    [Abstract] [Full Text] [Related]

  • 5. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats.
    Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V.
    Psychoneuroendocrinology; 2012 Nov 12; 37(11):1885-95. PubMed ID: 22541937
    [Abstract] [Full Text] [Related]

  • 6. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M, Muratsubaki T, Van Oudenhove L, Morishita J, Yoshizawa M, Kohno K, Yagihashi M, Tanaka Y, Mugikura S, Dupont P, Ly HG, Takase K, Kanazawa M, Fukudo S.
    Sci Rep; 2017 Sep 29; 7(1):12425. PubMed ID: 28963545
    [Abstract] [Full Text] [Related]

  • 7. A new soy germ fermented ingredient displays estrogenic and protease inhibitor activities able to prevent irritable bowel syndrome-like symptoms in stressed female rats.
    Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Houdeau E, Théodorou V.
    Clin Nutr; 2013 Feb 29; 32(1):51-8. PubMed ID: 22727545
    [Abstract] [Full Text] [Related]

  • 8. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S, Roeselers G, Levin E, Jonkers DM, Welting O, Heinsbroek SEM, de Weerd HH, Boekhout T, Fornai M, Masclee AA, Schuren FHJ, de Jonge WJ, Seppen J, van den Wijngaard RM.
    Gastroenterology; 2017 Oct 29; 153(4):1026-1039. PubMed ID: 28624575
    [Abstract] [Full Text] [Related]

  • 9. Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis.
    Liu YW, Wang YP, Yen HF, Liu PY, Tzeng WJ, Tsai CF, Lin HC, Lee FY, Jeng OJ, Lu CL, Tsai YC.
    Probiotics Antimicrob Proteins; 2020 Sep 29; 12(3):980-993. PubMed ID: 31691208
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological evaluation of a novel corticotropin-releasing factor 1 receptor antagonist T-3047928 in stress-induced animal models in a comparison with alosetron.
    Itomi Y, Tanaka T, Matsushita K, Kawamura T, Kojima T, Aso K, Matsumoto-Okano S, Tsukimi Y.
    Neurogastroenterol Motil; 2020 May 29; 32(5):e13795. PubMed ID: 31970891
    [Abstract] [Full Text] [Related]

  • 11. Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS).
    Zou N, Lv H, Li J, Yang N, Xue H, Zhu J, Qian J.
    Transl Res; 2008 Dec 29; 152(6):283-9. PubMed ID: 19059163
    [Abstract] [Full Text] [Related]

  • 12. The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression.
    Videlock EJ, Shih W, Adeyemo M, Mahurkar-Joshi S, Presson AP, Polytarchou C, Alberto M, Iliopoulos D, Mayer EA, Chang L.
    Psychoneuroendocrinology; 2016 Jul 29; 69():67-76. PubMed ID: 27038676
    [Abstract] [Full Text] [Related]

  • 13. [Electroacupuncture Relieves Visceral Hypersensitivity by Down-regulating Mast Cell Number，PAR-2/TRPV 1 Signaling, etc. in Colonic Tissue of Rats with Irritable Bowel Syndrome].
    Deng DX, Tan J, Zhang H, Huang GL, Li S, Guo KK, Wu YY, Yang BY, Xiao Y, Peng L, Xie H.
    Zhen Ci Yan Jiu; 2018 Aug 25; 43(8):485-91. PubMed ID: 30232850
    [Abstract] [Full Text] [Related]

  • 14. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B, Klooker TK, Wouters MM, Welting O, van der Loos CM, Stanisor OI, van Diest S, van den Wijngaard RM, Boeckxstaens GE.
    Am J Gastroenterol; 2012 May 25; 107(5):715-26. PubMed ID: 22488080
    [Abstract] [Full Text] [Related]

  • 15. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T.
    Eur J Pharmacol; 2020 Nov 15; 887():173565. PubMed ID: 32946869
    [Abstract] [Full Text] [Related]

  • 16. Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome.
    Heitkemper MM, Cain KC, Deechakawan W, Poppe A, Jun SE, Burr RL, Jarrett ME.
    Neurogastroenterol Motil; 2012 Jul 15; 24(7):626-31, e270-1. PubMed ID: 22471712
    [Abstract] [Full Text] [Related]

  • 17. Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.
    Coss-Adame E, Rao SS.
    Curr Gastroenterol Rep; 2014 Apr 15; 16(4):379. PubMed ID: 24595616
    [Abstract] [Full Text] [Related]

  • 18. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S.
    J Gastroenterol; 2007 Jan 15; 42 Suppl 17():48-51. PubMed ID: 17238026
    [Abstract] [Full Text] [Related]

  • 19. Altered psychobiological responsiveness in women with irritable bowel syndrome.
    Suárez-Hitz KA, Otto B, Bidlingmaier M, Schwizer W, Fried M, Ehlert U.
    Psychosom Med; 2012 Jan 15; 74(2):221-31. PubMed ID: 22286854
    [Abstract] [Full Text] [Related]

  • 20. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
    Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW.
    Gastroenterology; 2006 Feb 15; 130(2):304-11. PubMed ID: 16472586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.